drug
as of 2026-07-01huperzine 0.8 mg BID
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Biomedisyn Corporation
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Huperzine for Cognitive and Functional Impairment in Schizophrenia
NCT00963846Phase 2Completed
KOLs & investigators
1
Scott W. Woods, MDKOL score 8
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here